StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO) stock

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3028% above fair value
$686.79−4.54 (-0.66%)

Close on Nov 17, 2026Market cap $254.47BP/E 36.2Yield 0.25%

Thermo Fisher Scientific revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Thermo Fisher Scientific's revenue for the twelve months ending Sep 26, 2026 was $47.35B, up 8.3% year over year. For fiscal 2025 it was $44.56B, up 3.9% from the year before. Over ten years it grew 10.1% a year on average. The highest annual figure on record is $44.92B in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$44.56B+3.9%
FY2024Dec 31, 2024$42.88B+0.1%
FY2023Dec 31, 2023$42.86B-4.6%
FY2022Dec 31, 2022$44.92B+14.5%
FY2021Dec 31, 2021$39.21B+21.7%
FY2020Dec 31, 2020$32.22B+26.1%
FY2019Dec 31, 2019$25.54B+4.9%
FY2018Dec 31, 2018$24.36B+16.4%
FY2017Dec 31, 2017$20.92B+14.5%
FY2016Dec 31, 2016$18.27B+7.7%
FY2015Dec 31, 2015$16.97B+0.4%
FY2014Dec 31, 2014$16.89B+29.0%
FY2013Dec 31, 2013$13.09B+4.6%
FY2012Dec 31, 2012$12.51B+8.2%
FY2011Dec 31, 2011$11.56B+11.2%
FY2010Dec 31, 2010$10.39B+4.9%
FY2009Dec 31, 2009$9.91B-5.6%
FY2008Dec 31, 2008$10.50B+7.7%
FY2007Dec 31, 2007$9.75B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 26, 2026$12.14B+9.1%
Q2 FY2026Jun 27, 2026$11.99B+10.5%
Q1 FY2026Mar 28, 2026$11.01B+6.2%
Q4 FY2025Dec 31, 2025$12.22B+7.2%
Q3 FY2025Sep 27, 2025$11.12B+4.9%
Q2 FY2025Jun 28, 2025$10.86B+3.0%
Q1 FY2025Mar 29, 2025$10.36B+0.2%
Q4 FY2024Dec 31, 2024$11.40B+4.7%
Q3 FY2024Sep 28, 2024$10.60B+0.2%
Q2 FY2024Jun 29, 2024$10.54B-1.4%
Q1 FY2024Mar 30, 2024$10.35B-3.4%
Q4 FY2023Dec 31, 2023$10.89B-4.9%
Q3 FY2023Sep 30, 2023$10.57B-1.0%
Q2 FY2023Jul 1, 2023$10.69B-2.6%
Q1 FY2023Apr 1, 2023$10.71B-9.4%
Q4 FY2022Dec 31, 2022$11.45B+7.0%
Q3 FY2022Oct 1, 2022$10.68B+14.4%
Q2 FY2022Jul 2, 2022$10.97B+18.3%
Q1 FY2022Apr 2, 2022$11.82B+19.3%
Q4 FY2021Dec 31, 2021$10.70B+1.4%
Q3 FY2021Oct 2, 2021$9.33B+9.5%
Q2 FY2021Jul 3, 2021$9.27B+34.1%
Q1 FY2021Apr 3, 2021$9.91B+59.0%
Q4 FY2020Dec 31, 2020$10.55B+54.5%
Q3 FY2020Sep 26, 2020$8.52B+35.9%
Q2 FY2020Jun 27, 2020$6.92B+9.5%
Q1 FY2020Mar 28, 2020$6.23B+1.7%
Q4 FY2019Dec 31, 2019$6.83B+4.9%
Q3 FY2019Sep 28, 2019$6.27B+5.9%
Q2 FY2019Jun 29, 2019$6.32B+3.9%
Q1 FY2019Mar 30, 2019$6.13B+4.6%
Q4 FY2018Dec 31, 2018$6.51B+7.6%
Q3 FY2018Sep 29, 2018$5.92B+15.7%
Q2 FY2018Jun 30, 2018$6.08B+21.8%
Q1 FY2018Mar 31, 2018$5.85B+22.8%
Q4 FY2017Dec 31, 2017$6.05B+22.1%
Q3 FY2017Sep 30, 2017$5.12B–
Q2 FY2017Jul 1, 2017$4.99B–
Q1 FY2017Apr 1, 2017$4.77B–
Q4 FY2016Dec 31, 2016$4.95B–

More Thermo Fisher Scientific figures

See a number that looks wrong?